VanEck Pharmaceutical ETF
60 hedge funds and large institutions have $177M invested in VanEck Pharmaceutical ETF in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 19 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
8% less call options, than puts
Call options by funds: $419K | Put options by funds: $454K
32% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 19
Holders
60
Holding in Top 10
–
Calls
$419K
Puts
$454K
Top Buyers
| 1 | +$37.3M | |
| 2 | +$16.4M | |
| 3 | +$2.32M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.17M |
| 5 |
LCM
LVM Capital Management
Portage,
Michigan
|
+$477K |
Top Sellers
| 1 | -$6.54M | |
| 2 | -$3.26M | |
| 3 | -$3.03M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.18M |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$2.07M |